Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FD0E3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,598
Award facts
- Contract value 100% obligated
- $14,598.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pens on June 23, 2025, with a ceiling value of $14,598.18 and a firm fixed price structure. This delivery order represents a non-set-aside, competitively awarded contract for pharmaceutical procurement, with an ultimate completion date of June 24, 2025. The award was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare systems worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor for military and veteran healthcare systems. The company maintains a substantial portfolio of federal contract awards predominantly with the Defense Logistics Agency's Medical Supply Chain, delivering brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Zepbound—a diabetes treatment medication—is consistent with AmerisourceBergen's extensive experience fulfilling federal medical supply requirements through open competition and demonstrates the company's continued role as a primary pharmaceutical vendor for the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FD0E3?
SPE2DB25FD0E3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 23, 2025.
How much is contract SPE2DB25FD0E3 worth?
The government has obligated $14,598 on SPE2DB25FD0E3.
Is contract SPE2DB25FD0E3 an order under another contract?
Yes. SPE2DB25FD0E3 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FD0E3 competed?
The extent of competition for SPE2DB25FD0E3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award